Advanced wound care comprises products that are used to treat acute and chronic wounds, such as ulcers, burns and post-operative wounds. The advanced wound care products such as film and foam dressings, hydrogels, alginates and hydrocolloids keeps the wound hydrated to encourage healing without occluding the wound. Health care professionals are emphasizing on the importance of keeping a wound moderately damp and are prescribing advanced wound care products for more severe wounds such as amputations and deep laceration. This type of treatment is expensive, however, prominent due to its effectiveness and faster healing process. Besides healing, advanced wound care products have various advantages over conventional wound care products viz. constant temperature around the wound, regulate oxygen flow, provide barrier to bacterial & microbial penetration, reduces complications, and protect wound from infection.
Increasing number of diabetic patients, rising incidences of chronic wounds, growing geriatric population and other debilitating diseases have increased the demand for advanced wound care products. Besides this, the demand for advanced wound care products has also risen due to potential benefits and the presence of therapeutic substances that help in faster and scar free healing. However, the treatment of wound depends on its type and severity. Conventional wound care products such as gauze, lint, plasters and wadding are still preferred for non-severe wounds, to absorb fluids, stop bleeding, inhibit infection, dry the wound. The advanced wound care market is also restricted due to high cost compared to conventional wound care products.
The Asian advanced wound care market is segmented based on type, application, end user and geography. The type of advanced wound care market is sub segmented into dressing and graft. The dressing is further categorized as collagen products, foam dressings, gauze, hydrocolloids, hydrogels, alginate dressings, film dressings, and antimicrobial dressings, while grafts are classified into composite skin grafts and biologic grafts. On the basis of application, the market is classified into surgical wound, ulcer, and other wounds. The ulcer application market is sub segmented into diabetic foot ulcers, pressure ulcers, venous ulcers, and arterial ulcers. The end user market is categorized into in-patient and out-patient. Geographically, the market comprises China, Japan, India, Republic of Korea (RoK) and Rest of Asia (RoA).
The key market players profiled in the report are Smith and Nephew PLC, Molnlycke Healthcare, Integra Life Sciences Corporation, Medline Industries Inc., Convatec Inc., Coloplast Group, Shire PLC, Organogenesis Inc., Medline Industries Inc., MiMedx Group Inc., Laboratories Urgo, and Systagenix. Product launch, acquis ions and mergers are few of the key strategies implemented by key market players to strengthen their position in market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
Asian Advanced Wound Care Market By Method
Asian Advanced Wound Care Market By Application
Asian Advanced Wound Care Market By End User
Asian Advanced Wound Care Market By Geography